RANIRani Therapeutics Holdings, Inc.同业对比
Rani Therapeutics Holdings, Inc. 与Pharmaceutical Preparations的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Pharmaceutical Preparations)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RANI本股 | $149M#6 | — | 3.8x#3 | 91.3x#2 | 58.9%#3 | 1.1%#9 | -2346.0%#10 | -75.6%#5 | — | — | 70.2%#2 | — |
| PVCT | — | — | — | — | -45.5%#11 | 15.6%#5 | -1575.3%#9 | — | — | — | — | — |
| QNRX | $483M#5 | — | 122.8x#6 | — | — | -75.6%#10 | — | -401.8%#8 | — | — | -20.1%#7 | — |
| QNTM | $44#9 | — | — | — | — | — | — | — | — | — | -81.7%#10 | — |
| QUCY | $116M#7 | — | 5.7x#4 | 216.0x#4 | -39.9%#9 | 24.9%#1 | -3005.0%#11 | -79.6%#6 | -203.8%#3 | — | -14.6%#5 | — |
| QURE | $2.8B#4 | — | 18.7x#5 | 173.3x#3 | -40.6%#10 | 16.9%#4 | -1151.4%#8 | -133.3%#7 | -263.3%#4 | — | 200.1%#1 | — |
| RADX | $4.2B#3 | — | — | 1152.1x#5 | 1114.3%#1 | 20.0%#2 | -1050.6%#6 | — | — | — | -75.2%#9 | — |
| RCKTW | $285414#8 | — | 0.0x#1 | — | — | 13.8%#6 | — | -60.5%#4 | — | — | -94.8%#11 | — |
| RDHL | $29.7B#1 | — | — | 3691.2x#6 | 23.2%#4 | -134.6%#13 | -181.7%#5 | — | — | — | -65.1%#8 | — |
| RDPTF | — | — | — | — | 1114.3%#1 | 20.0%#2 | -1050.6%#6 | — | — | — | — | — |
| RDY | $10.2B#2 | — | 2.6x#2 | 2.7x#1 | 13.8%#5 | — | 22.1%#2 | 17.0%#1 | — | — | -17.2%#6 | 0.8%#1 |
| REGN | — | 19.4x#1 | — | — | 1.0%#6 | 2.1%#8 | 24.9%#1 | 14.2%#2 | 9.4%#1 | — | 31.0%#3 | — |
| RFL | — | — | — | — | — | 11.3%#7 | -97196.7%#12 | -40.5%#3 | -43.7%#2 | — | 29.7%#4 | — |
| RGBP | — | — | — | — | 0.0%#7 | -90.7%#11 | -143.1%#3 | — | — | — | — | — |
| RGBPP | — | — | — | — | 0.0%#7 | -90.7%#11 | -143.1%#3 | — | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-18。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议